Article
Rhenium Perrhenate (188ReO4) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells.
Cells - 17 Jan 2022
Asadian Samieh, Piryaei Abbas, Gheibi Nematollah, Aziz Kalantari Bagher, Reza Davarpanah Mohamad, Azad Mehdi, Kapustina Valentina, Alikhani Mehdi, Moghbeli Nejad Sahar, Keshavarz Alikhani Hani, Mohamadi Morteza, Shpichka Anastasia, Timashev Peter, Hassan Moustapha, Vosough Massoud
Abstract excerpt
Recurrence in hepatocellular carcinoma (HCC) after conventional treatments is a crucial challenge. Despite the promising progress in advanced targeted therapies, HCC is the fourth leading cause of cancer death worldwide. Radionuclide therapy can potentially be a practical targeted approach to address this concern. Rhenium-188 (188Re) is a β-emitting radionuclide used in the clinic to induce apoptosis and inhibit...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
